Molecular mechanisms of pyroptosis and its role in anti-tumor immunity

Hongyong Huang1, Yanmin Weng1, Wen Tian1

  • 1The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China.

Insights

Pyroptosis, a cell death form, involves gasdermin-activated pore formation and inflammatory release. Understanding pyroptosis is crucial for developing novel cancer immunotherapies targeting tumor immunity.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Pyroptosis is a pro-inflammatory form of programmed cell death.
  • The gasdermin family mediates pyroptosis through membrane pore formation.
  • Pyroptosis plays a role in host defense and inflammation.

Purpose of the Study:

  • To review the mechanisms of pyroptosis.
  • To explore the role of gasdermins in pyroptosis.
  • To discuss the implications of pyroptosis in cancer immunotherapy.

Main Methods:

  • Literature review of pyroptosis mechanisms.
  • Analysis of gasdermin family functions.
  • Examination of pyroptosis's role in anti-tumor immunity.

Main Results:

  • Pyroptosis involves inflammasome activation and gasdermin-mediated pore formation.
  • Pyroptosis contributes to anti-tumor immunity by releasing inflammatory factors.
  • Dysregulation of pyroptosis is implicated in cancer progression.

Conclusions:

  • Pyroptosis is a promising target for cancer immunotherapy.
  • Further research into pyroptosis mechanisms can lead to novel therapeutic strategies.
  • Targeting pyroptosis may enhance the immune system's ability to fight cancer.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
959
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K